Lee Nadler is principal investigator for Harvard Catalyst (CTSA UM1 grant) and dean for clinical and translational research at Harvard Medical School (HMS). He is the Virginia and D.K. Ludwig Professor for Cancer Research and Teaching at HMS, as well as senior vice president for academic integration and the Pan Mass Challenge senior investigator at Dana-Farber Cancer Institute. Nadler has been recognized with numerous awards for his pioneering efforts in the discovery and development of revolutionary treatments for cancer patients. He was the founding chief of the Division of Hematologic Malignancies and founding chair of the Department of Medical Oncology at Dana-Farber. He also served as the first leader of the Center for Clinical and Translational Research at Dana-Farber. As director of Harvard Catalyst, he and his colleagues have worked to bring investigators together as “One Harvard” to begin to solve major issues in human health.
Lee Nadler, MD
Principal Investigator, Harvard Catalyst
Dean, Clinical and Translational Research